1.Effects on Weight Reduction and Safety of Short-Term Phentermine Administration in Korean Obese People.
Kyoung Kon KIM ; Hi Jung CHO ; Hee Cheol KANG ; Bang Bu YOUN ; Kyu Rae LEE
Yonsei Medical Journal 2006;47(5):614-625
The phentermine, an appetite suppressant, has been widely applied in Korea since 2004. However, there have been relatively few reports about the efficacy and the safety of phentermine in Korea. The aim of this study is to verify the effect of phentermine on weight reduction and the safety in Korean patients. This randomized, double-blind, placebo- controlled study had been performed between February and July, 2005, in Seoul on 68 relatively healthy obese adults whose body mass index was 25 kg/m2 or greater. They received phentermine-HCl 37.5 mg or placebo once daily with behavioral therapy for obesity. The primary endpoints were the changes of body weight and waist circumference from the baseline in the intention-to-treat population. Mean decrease of both body weight and waist circumference in phentermine-treated subjects were significantly greater than that of placebo group (weight: -6.7 +/- 2.5 kg, p < 0.001; waist circumference: -6.2 +/- 3.5 cm, p < 0.001). Significant number of subjects in phentermine group accomplished weight reduction of 5% or greater from the baseline and 10% or more (p < 0.001). There were no significant differences in systolic and diastolic blood pressure between the groups (p = 0.122 for systolic BP; p = 0.219 for diastolic BP). Dry mouth and insomnia were the only statistically significant adverse events that occurred more frequently in phentermine group. Most side effects of phentermine were mild to moderate in intensity. Short-term phentermine administration induced significant weight reduction and reduction of waist circumference without clinically problematic adverse events on relatively healthy Korean obese people.
Weight Loss/*drug effects
;
Risk Factors
;
Phentermine/administration & dosage/adverse effects/*therapeutic use
;
Obesity/*drug therapy
;
Male
;
Korea
;
Humans
;
Female
;
Double-Blind Method
;
Appetite Depressants/administration & dosage/adverse effects/*therapeutic use
;
Adult
2.Change of peripheral blood appetite regulation factor of anorexia children and infect of child anorexia granule.
Ai-Hua HU ; Hui-Min XU ; Guo-Hua HU ; Fang JIN ; Zhong LI ; Guo-Xing FANG
China Journal of Chinese Materia Medica 2014;39(23):4685-4688
Study the infect of child anorexia granule on serum ghrelin and leptin of anorexia children and its clinical efficacy. Selected 81 cases of anorexia children aged 1-6 years old into treatment group (42 cases) and control group (39 cases), in addition, 30 case healthy children as healthy control group. The control group children were treated with domperidone suspension 0.3 mg x kg(-1) x d(-1), tid, orally 30 minutes before meals. Treatment group were treated with child anorexia granule, 1-3 years 1 package, bid; 4-6 years 1 package, tid; po, 4 weeks as a course of treatment. Study the change of serum ghrelin and leptin before and after therapy. The study demonstrates that before treatment, the serum ghrelin level of disease group was lower than healthy group (P < 0.01), and the serum leptin level was higher than healthy group (P < 0.01). After treatment, the serum ghrelin level both increase, and the serum leptin decline. And the change of treatment group was significantly different with control group (P < 0.01). And the clinical effective rate are 95.23% and 74.35% (P < 0.01). After 6 months of follow-up visit, the children weight significantly increase in treatment group (P < 0.01). Results indicate that child anorexia granule can facilitate secretion of ghrelin, and inhibit secretion of leptin, so as to work up an appetite. And the molecular mechanism is its infect on serum ghrelin, leptin.
Anorexia
;
drug therapy
;
metabolism
;
physiopathology
;
Appetite Regulation
;
drug effects
;
Body Weight
;
drug effects
;
Child
;
Child, Preschool
;
Drugs, Chinese Herbal
;
administration & dosage
;
Female
;
Ghrelin
;
metabolism
;
Humans
;
Infant
;
Leptin
;
metabolism
;
Male
3.Changes of body weight and galanin in epileptic children treated with topiramate.
Rong-fu SHI ; Ke-ling WANG ; Qing-hua LI ; Hua-cheng ZHENG ; Hua-fang YANG ; Hong-xia TANG ; Su-zhen SUN ; Li-hui WANG ; Jie TIAN
Chinese Journal of Pediatrics 2007;45(3):199-202
OBJECTIVETopiramate is a new broad-spectrum anti-epileptic drug. Decreased body weight and appetite are common side effects of topiramate. The side effect affects the growth and development in children greatly. Little is known about the mechanisms of topiramate-induced weight loss and decreased appetite in children with epilepsy in China and abroad. galanin is one of factors that affect appetite. It is a neuroendocrine peptide and play an important role in the control of appetite and body weight in the mechanism of hormone release. The purpose of this study was to explore the mechanism of topiramate-induced weight loss in children with epilepsy and the relation of weight loss with change of galanin, thereby to provide evidences for improvement of quality of life, compliance to treatment and reduce side effects of growth and development in children with epilepsy.
METHODSTotally 61 patients with especial epilepsy were enrolled into this study and the disease was defined by clinical manifestations and electroencephalography (EEG). Among them 32 cases had generalized seizures and 29 had local seizures. Sixteen normal children were enrolled as control group. The patients' age ranged from 0.5 to 14 (4.76 +/- 4.05) years and the patients were instructed to take 0.5 - 1 mg/kg of topiramate per day, with 0.5 - 1 mg/kg every 3 - 5 d increased to maximum of 3 - 8 mg/kg per day. Patients continued receiving the doses for 4 months. All patients' serum galanin levels and body height and weight and hepatic function were detected before and after antiepileptic drugs treatment. The galanin was detected by using radioimmunoassay.
RESULTSAfter treatment with topiramate (61 cases) for 4 months, plasma galanin [(22.01 +/- 8.12) pg/ml] declined as compared with baseline [(26.56 +/- 9.35) pg/ml, t = 2.85, P < 0.01] in children with epilepsy. Twenty-two of 61 patients lost weight, their plasma galanin concentration was significantly lower [(26.51 +/- 10.00) pg/ml vs. (20.45 +/- 8.09) pg/ml, t = 2.91, P < 0.01], but there was no significant change in the weight-gained patients (39/61) and control group (n = 16). In children with epilepsy, the mean value of body weight decreased as compared with the pre-treatment values, but the difference was not significant; however, the body-mass index (BMI) was significantly lower than that obtained before treatment (t = 8.628, P < 0.01). Eighteen of 22 patients who lost weight had decreased appetite, but only five of 39 patients who gained weight showed decreased appetite (chi(2) = 28.50, P < 0.001). The mean value of plasma galanin declined after treatment in patients (23 cases) with decreased appetite [(18.35 +/- 7.80) pg/ml vs. (27.28 +/- 6.90) pg/ml, t = 4.84, P < 0.001]; while plasma galanin did not change significantly after treatment in patients (38 cases) without decreased appetite [(24.23 +/- 7.66) pg/ml vs. (26.12 +/- 5.49) pg/ml, t = 1.04, P > 0.05].
CONCLUSIONTopiramate treatment may lower the body weight and reduce appetite in part of children with epilepsy which may be mediated by the reduced plasma galanin level.
Adolescent ; Anticonvulsants ; therapeutic use ; Appetite ; drug effects ; Case-Control Studies ; Child ; Child, Preschool ; Epilepsy ; drug therapy ; Female ; Fructose ; analogs & derivatives ; therapeutic use ; Galanin ; blood ; Humans ; Infant ; Male ; Weight Loss ; drug effects
4.Multi-centered clinical study on effects of nano-amomi paste in treating children's anorexia.
Min WU ; Zhan LI ; Jian-Er YU ; Wei-wei LU ; Ju-xiu NI ; Yi-lin XIA
Chinese journal of integrative medicine 2007;13(1):55-58
OBJECTIVETo assess the effect and safety of nano-Amoni Paste (nmAP) in the treatment of children's anorexia (AR).
METHODSOne hundred and eighty patients of AR were assigned according to the randomized, double-blinded, double-simulated and parallel controlled principle to three groups, the treated group (TG), the positive control group (PCG) and the negative control group (NCG), 60 in each group. The patients in TG were treated by sticking 1.5 ml of nmAP on the acupoint of Shenque (Ren 8) once a day and orally taking placebo liquid 10 ml twice a day; those in PCG and NCG treated with sticking paste of placebo on Ren 8, and oral taking of Shanmai Jianpi Oral Liquid and placebo liquid respectively, 10 ml each time twice per day. The course of treatment for all was 10 days, all patients were treated for 2 courses.
RESULTSThe total effective rate and the effective rate on cardinal symptom in TG was 85.0% and 95.0% respectively, that in PCG 86.2% and 96.55% and in NCG 45.5% and 65.45%, respectively, showing significant difference between groups (P<0.05). Comparison of the clinical manifestation before and after treatment showed significant improvement in volume of food intake, appetite, complexion and reduction of restlessness symptom (P<0.05) in all three groups, and there was no adverse reaction found in them.
CONCLUSIONnmAP is an effective and safe remedy for treatment of Children's anorexia.
Acupuncture Points ; Amomum ; chemistry ; Anorexia ; physiopathology ; therapy ; Appetite ; drug effects ; Body Height ; drug effects ; Body Weight ; drug effects ; Child ; Child, Preschool ; Double-Blind Method ; Eating ; drug effects ; Female ; Humans ; Liposomes ; Male ; Nanoparticles ; Oils, Volatile ; administration & dosage ; adverse effects ; isolation & purification ; therapeutic use ; Ointments ; Phytotherapy ; Plant Extracts ; administration & dosage ; adverse effects ; therapeutic use ; Psychomotor Agitation ; physiopathology ; Treatment Outcome
5.Expression of oxyntomodulin in bifidobacteria and effect of oxyntomodulin-transformed bifidobacteria on the body weight of obese mice.
Ruo-ting LONG ; Wei-sen ZENG ; Shen-qiu LUO ; Jiao GUO ; Yuan-zao LIN ; Qing-song HUANG
Journal of Southern Medical University 2009;29(9):1796-1798
OBJECTIVETo observe the effect of pBBADs-OXM-transformed bifidobacteria on the body weight of obese mice.
METHODSB. longum was transformed with pBBADs-OXM by electroporation, and arabopyranose-induced oxyntomodulin expression by the bacterium was detected by ELISA. pBBADs-OXM-transformed bifidobacteria was administered orally obese mice on a daily basis with pBBADs-GFP-transformed bifidobacteria as the negative control, and the body weight changes of the mice were observed.
RESULTSOXM was detected by ELISA not only in the supernatant but also the precipitant of the transformed bacterial culture. The body weight of the obese mice fed with pBBADs-OXM-transformed bifidobacteria decreased significantly compared with that of the mice in the obese model group (P<0.05).
CONCLUSIONAdministration of pBBADs-OXM-transformed B.longum can reduce the body weight of obese mice.
Administration, Oral ; Animals ; Appetite Depressants ; administration & dosage ; metabolism ; Bifidobacterium ; genetics ; metabolism ; Body Weight ; drug effects ; Electroporation ; Escherichia coli ; genetics ; metabolism ; Mice ; Obesity ; drug therapy ; Oxyntomodulin ; administration & dosage ; biosynthesis ; genetics ; Random Allocation ; Recombinant Proteins ; administration & dosage ; biosynthesis ; genetics
6.Moresby food isn’t good: food security, nutritional information and adherence to antiretroviral therapy in Papua New Guinea.
Kelly A ; Mek A ; Frankland A ; Akunai F ; Kepa B ; Kupul M ; Nosi S ; Cangah B ; Walizopa L ; Pirpir L ; Emori R ; Worth H ; Siba PM ; Man WY.
Papua New Guinea medical journal 2011;54(1-2):23-34
The relationship between HIV (human immunodeficiency virus), food security and nutrition has become increasingly important to practitioners, policy makers and people living with HIV. In this paper we describe for the first time the connection between HIV and antiretroviral therapies, the extent of nutritional counselling for HIV-positive people and food security in Papua New Guinea (PNG). A total of 374 HIV-positive people who were over the age of 16 and who had been on antiretroviral therapy (ART) for more than two weeks were recruited from six provinces, using a non-probability, convenience sampling methodology. A subsample of 36 participants also completed an in-depth qualitative interview. Participants received nutritional advice when beginning ART which focused on three main domains, of which the first two were the most frequently mentioned: what foods to avoid; what foods to eat; and how frequently to eat. 72% of the sample reported that they had experienced an increase in their appetite. Of those who reported that their appetite had increased on ART 33% reported that they did not have enough food to satisfy hunger. People who lived in the capital city, Port Moresby, within the Southern Region of PNG, had significantly more difficulty with food security than those who lived in other regions of the country. Not having enough food was the third most commonly recorded reason for non-adherence to ART. Responses to the HIV epidemic in Papua New Guinea must also begin to address the phenomenon of food insecurity for people with HIV, in particular those who are receiving antiretroviral therapies and who live in the urban areas.
Adolescent
;
Adult
;
Aged
;
Anti-Retroviral Agents/*therapeutic use
;
Appetite/*drug effects
;
*Counseling
;
Female
;
*Food Supply
;
HIV Infections/*drug therapy
;
Humans
;
Male
;
*Medication Adherence
;
Middle Aged
;
Papua New Guinea
;
Qualitative Research
;
Urban Population
;
Young Adult
7.Changes of Body Weight and Inflammatory Markers after 12-Week Intervention Trial: Results of a Double-Blind, Placebo-Control Pilot Study.
Nam Seok JOO ; Sang Man KIM ; Kwang Min KIM ; Chan Won KIM ; Bom Taeck KIM ; Duck Joo LEE
Yonsei Medical Journal 2011;52(2):242-248
PURPOSE: Low grade inflammation is a well-known characteristic in obese subjects. We investigated body weight changes and inflammatory markers after 12-week intervention trial. MATERIALS AND METHODS: Twenty-six obese subjects were enrolled and 19 (13 men and 6 women) completed the study. Sibutramine is an FDA-approved drug for body weight control; therefore, we chose this drug as the standard treatment medication in this study. Patients were randomly allocated to receive an anti-inflammatory agent (Diacerein treatment group; n = 12) or placebo (n = 7) for 12 weeks. Anthropometry, body proportion by dual-energy X-ray absorptiometry, and metabolic parameters at the beginning and end of study were measured and compared. RESULTS: The treatment group had a tendency towards more reduction in anthropometry as compared to the placebo group, in body weight reduction (- 7.0 kg vs. - 4.6 kg), body mass index (- 2.51 kg/m2 vs. - 1.59 kg/m2), and waist circumference (- 7.3 cm vs. - 4.4 cm). These reductions were not statistically significant. Changes in levels of high-sensitivity C-reactive protein and adiponectin in the treatment group were more favorable than in the placebo group. CONCLUSION: This small pilot study showed no statistical difference for changes in anthropometry, and inflammatory markers between the two groups. Therefore, we could not find any additional effects of Diacerein on weight loss and inflammatory variables in this study.
Absorptiometry, Photon
;
Adiponectin/blood
;
Adult
;
Anthraquinones/*therapeutic use
;
Anti-Inflammatory Agents/*therapeutic use
;
Appetite Depressants/therapeutic use
;
C-Reactive Protein/analysis
;
Cyclobutanes/*therapeutic use
;
Double-Blind Method
;
Female
;
Humans
;
Inflammation
;
Lipoproteins, LDL/blood
;
Male
;
Obesity/*drug therapy/immunology
;
Pilot Projects
;
Tumor Necrosis Factor-alpha/blood
;
Waist Circumference/drug effects/immunology
;
Weight Loss/drug effects/*immunology
8.The study on mechanism of appetite regulation in diet-induced obesity resistant rats.
Rong LIU ; Chang-hao SUN ; Ying WENG
Chinese Journal of Preventive Medicine 2005;39(2):119-121
OBJECTIVETo explore the cause of decreasing intake food of diet-induced obesity resistant (DIO-R) rats.
METHODSFifty male Sprague-dawley (SD) rats were randomly divided into control group and high-fat group and they were fed with basic diet and high-fat diet respectively for 13 weeks. DIO-R and diet-induced obesity (DIO) rats were selected according to their body weight and the quantity of energy intake, then observing the changes of the total food intake, the level of serum leptin and plasma NPY were determined by radioimmunoassay and the contents of the melanocortin receptor-4 (MCR-4) in brain were determined by Western Blot.
RESULTSThe total food intake of DIO-R rats was (1 679.1 +/- 146.8) g. The total food intake of DIO rats was (1 818.4 +/- 148.9) g. The total food intake of DIO-R rats was lower than that of DIO rats (P < 0.05). The level of plasma NPY of DIO-R rats was (795.24 +/- 83.59) ng/L. The level of plasma NPY of DIO rats was (1 007.14 +/- 172.83) ng/L. The level of plasma NPY of DIO-R rats was lower than that of the DIO rats (P < 0.05). The levels of serum leptin of basic, DIO-R and DIO rats was (4.80 +/- 0.75) microg/L, (9.17 +/- 1.19) microg/L and (9.32 +/- 1.04) microg/L. The level of serum leptin of rats in high-fat diet group was increased as compared with the rats in basic diet group, but there was no significant difference between DIO-R and DIO rats (P > 0.05). The levels of brain MCR-4 of basic, DIO-R and DIO rats were (342 +/- 31) mm2, (455 +/- 33) mm2, (355 +/- 30) mm2. High fat diets increased the content of brain MCR-4 in DIO-R rats.
CONCLUSIONDIO-R rats decreased appetite by increasing expression of ob gene to reduce activity of NPY pathway and activate the MCR-4 pathway, and thus inhibit the increase body of weight.
Animals ; Appetite ; physiology ; Blotting, Western ; Body Weight ; physiology ; Brain ; drug effects ; metabolism ; Dietary Fats ; administration & dosage ; Disease Models, Animal ; Energy Intake ; physiology ; Leptin ; blood ; Male ; Neuropeptide Y ; blood ; Obesity ; blood ; etiology ; physiopathology ; Radioimmunoassay ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptor, Melanocortin, Type 4 ; metabolism